Home
Conditions
Colitis, Ulcerative

Clinical trial condition

Colitis, Ulcerative

Explore clinical trials studying Colitis, Ulcerative. Study availability and eligibility vary by location and protocol.

1,288 public trials 248 recruiting studies

Refine in advanced search Browse all conditions

Colitis, Ulcerative trial results

Completed

Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults

NCT02209987

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: Christchurch, New Zealand

View Trial Details

Completed

Disease Course in an IBD Cohort in the Era of Biological Treatment

NCT01468090

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +12 more
Locations: Hvidovre Hospital, Gastroenheden 360 Hvidovre, Denmark

Hvidovre hospital Hvidovre, Denmark

View Trial Details

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease

NCT01666327

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +7 more
Locations: Research Site Nottingham, United Kingdom

View Trial Details

Completed

A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT00853099

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: Site Reference ID/Investigator# 47136 Asahikawa, Japan

Site Reference ID/Investigator# 47159 Chiba, Japan

Site Reference ID/Investigator# 47183 Chikushino-shi, Japan

Site Reference ID/Investigator# 47135 Fukuoka, Japan

View all 65 locations

View Trial Details

Completed

Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

NCT00347048

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: Chubu Region, Japan

Hokkaido Region, Japan

Kansai Region, Japan

Kanto Region, Japan

View Trial Details

Completed

Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

NCT00643071

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: Chūbu, Japan

Hokkaido, Japan

Kansai, Japan

Kanto, Japan

View Trial Details

Completed

Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis

NCT01177228

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

NCT00783718

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Apex Clinical Trials Birmingham, Alabama, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

Gastrointestinal Bioscience Los Angeles, California, United States

View all 105 locations

View Trial Details

Completed

Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

NCT00619489

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +8 more
Locations: London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis

NCT01506362

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: Soroka Medical Center Beersheba, Israel

Rambam Medical Center Haifa, Israel

Hadassah medical center Jerusalem, Israel

Shaare Zedek Medical center Jerusalem, Israel

View Trial Details

Colitis, Ulcerative

Colitis, Ulcerative trial results

Related conditions